Home / Inspections / 1162330

FDA Inspection 1162330 — UCLA Health, Component Processing Laboratory, Hematologic Malignancies/Stem Cell Transplantation Program

UCLA Health, Component Processing Laboratory, Hematologic Malignancies/Stem Cell Transplantation Program — FEI 2074237

The FDA completed an inspection of UCLA Health, Component Processing Laboratory, Hematologic Malignancies/Stem Cell Transplantation Program on February 10, 2022 in Los Angeles, CA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
February 10, 2022
Fiscal Year
2022
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Los Angeles, CA (United States)

Facility

Other inspections at this facility

  • 1289160 (NAI Mon Sep 29 2025 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1226838 (NAI Thu Jan 04 2024 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1100640 (NAI Wed Jun 19 2019 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1065401 (NAI Thu Jul 12 2018 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 981667 (NAI Thu Jul 07 2016 00:00:00 GMT+0000 (Coordinated Universal Time))

FDA data resources